Total Payments
$468.05
2022 Payments
$30.58
Companies
14
Transactions
25
Medicare Patients
1,600
Medicare Billing
$131,470
Payment Breakdown by Category
Food & Beverage$468.05 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $468.05 | 25 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $92.21 | 6 | $0 (2019) |
| Horizon Therapeutics plc | $81.79 | 1 | $0 (2019) |
| Novo Nordisk Inc | $63.00 | 4 | $0 (2018) |
| Allergan, Inc. | $38.57 | 2 | $0 (2020) |
| Mentor Worldwide LLC | $30.58 | 1 | $0 (2022) |
| GlaxoSmithKline, LLC. | $25.65 | 2 | $0 (2018) |
| Merz North America, Inc. | $22.65 | 1 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.70 | 2 | $0 (2017) |
| Lilly USA, LLC | $17.30 | 1 | $0 (2017) |
| PFIZER INC. | $16.11 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $30.58 | 1 | Mentor Worldwide LLC ($30.58) |
| 2020 | $27.82 | 1 | Allergan, Inc. ($27.82) |
| 2019 | $135.00 | 5 | Horizon Therapeutics plc ($81.79) |
| 2018 | $127.79 | 8 | Novo Nordisk Inc ($34.33) |
| 2017 | $146.86 | 10 | AstraZeneca Pharmaceuticals LP ($36.16) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/16/2022 | Mentor Worldwide LLC | ARTOURA Breast Tissue Expander (Device), MENTOR MemoryGel Resterilizable Gel Sizer | Food and Beverage | In-kind items and services | $30.58 | General |
| Category: Plastic Surgery | ||||||
| 10/27/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $27.82 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | Cash or cash equivalent | $81.79 | General |
| Category: KRYSTEXXA | ||||||
| 07/08/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/07/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Neuroscience | ||||||
| 02/28/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $11.64 | General |
| Category: Respiratory | ||||||
| 01/09/2019 | Medtronic USA, Inc. | PlasmaBlade (Device) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Advanced Energy Cutting Device | ||||||
| 10/04/2018 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $10.75 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/02/2018 | Merz North America, Inc. | XEOMIN (Biological), ASCLERA | Food and Beverage | Cash or cash equivalent | $22.65 | General |
| Category: DERMATOLOGY | ||||||
| 06/04/2018 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Vascepa | Food and Beverage | Cash or cash equivalent | $16.01 | General |
| Category: Cardiovascular | ||||||
| 05/31/2018 | GlaxoSmithKline, LLC. | ADVAIR (Drug), FLOVENT, BREO | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: RESPIRATORY | ||||||
| 05/08/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/10/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Diabetes | ||||||
| 03/29/2018 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Respiratory | ||||||
| 02/19/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Diabetes | ||||||
| 12/19/2017 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: Respiratory | ||||||
| 12/01/2017 | GlaxoSmithKline, LLC. | SHINGRIX (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: VACCINES | ||||||
| 11/30/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Diabetes | ||||||
| 11/09/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $10.89 | General |
| Category: RESPIRATORY | ||||||
| 07/27/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/03/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Diabetes | ||||||
| 06/22/2017 | PFIZER INC. | LYRICA (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 04/13/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO (Drug) | Food and Beverage | In-kind items and services | $10.81 | General |
| Category: RESPIRATORY | ||||||
| 01/31/2017 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: Respiratory | ||||||
| 01/12/2017 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 10 | 535 | 798 | $105,421 | $46,782 |
| 2021 | 8 | 583 | 800 | $88,316 | $41,919 |
| 2020 | 9 | 482 | 852 | $112,808 | $42,769 |
Total Patients
1,600
Total Services
2,450
Medicare Billing
$131,470
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 103 | 261 | $58,464 | $24,049 | 41.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 67 | 67 | $16,281 | $8,982 | 55.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 51 | 69 | $10,628 | $3,750 | 35.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 57 | 80 | $7,280 | $3,197 | 43.9% |
| 0134A | Fee covid-19 vac 14 res | Office | 2022 | 47 | 47 | $2,820 | $1,862 | 66.0% |
| 0064A | Adm sarscov2 50mcg/0.25mlbst | Office | 2022 | 40 | 41 | $2,460 | $1,641 | 66.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 12 | $3,636 | $1,499 | 41.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 63 | 63 | $2,394 | $1,181 | 49.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 78 | 141 | $846.00 | $418.68 | 49.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 17 | 17 | $612.00 | $203.47 | 33.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 75 | 129 | $28,896 | $12,065 | 41.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 80 | 154 | $23,562 | $10,055 | 42.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 72 | 72 | $17,496 | $9,907 | 56.6% |
| 0013A | Fee covid-19 vac 2 booster | Office | 2021 | 110 | 110 | $6,600 | $4,483 | 67.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 66 | 82 | $7,462 | $3,355 | 45.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 71 | 71 | $2,698 | $1,360 | 50.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 94 | 165 | $990.00 | $495.00 | 50.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 15 | 17 | $612.00 | $199.84 | 32.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 111 | 294 | $44,982 | $15,213 | 33.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 69 | 137 | $30,688 | $11,511 | 37.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 59 | 59 | $14,337 | $7,187 | 50.1% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2020 | 18 | 24 | $11,592 | $4,613 | 39.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 14 | 14 | $4,872 | $1,408 | 28.9% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 44 | 65 | $2,665 | $1,078 | 40.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 54 | 54 | $2,052 | $1,026 | 50.0% |
About Dr. Mitchell Marks, D.O
Dr. Mitchell Marks, D.O is a Internal Medicine healthcare provider based in Palm Beach Gardens, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1972599199.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mitchell Marks, D.O has received a total of $468.05 in payments from pharmaceutical and medical device companies, with $30.58 received in 2022. These payments were reported across 25 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($468.05).
As a Medicare-enrolled provider, Marks has provided services to 1,600 Medicare beneficiaries, totaling 2,450 services with total Medicare billing of $131,470. Data is available for 3 years (2020–2022), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Palm Beach Gardens, FL
- Active Since 09/22/2005
- Last Updated 11/05/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1972599199
Products in Payments
- KRYSTEXXA (Biological) $81.79
- Victoza (Drug) $63.00
- SYMBICORT (Drug) $50.80
- ARTOURA Breast Tissue Expander (Device) $30.58
- FARXIGA (Drug) $28.51
- UBRELVY (Drug) $27.82
- XEOMIN (Biological) $22.65
- STIOLTO (Drug) $21.70
- TRULICITY (Drug) $17.30
- LYRICA (Drug) $16.11
- Livalo (Drug) $16.01
- Aimovig (Biological) $15.45
- PlasmaBlade (Device) $14.26
- SHINGRIX (Drug) $14.15
- BEVESPI AEROSPHERE (Drug) $12.90
- JANUVIA (Drug) $12.77
- ADVAIR (Drug) $11.50
- LINZESS (Drug) $10.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Palm Beach Gardens
Dr. Ravi Pandey, Md, MD
Internal Medicine — Payments: $17,395
Internal Medicine $17,395
Dr. Rupesh Dharia, M.d, M.D
Internal Medicine — Payments: $15,087
Internal Medicine $15,087
Amir Fahmy, Md, MD
Internal Medicine — Payments: $12,315
Internal Medicine $12,315
Romel Arjona, M.d, M.D
Internal Medicine — Payments: $9,757
Internal Medicine $9,757
Alissa O'brien, M.d, M.D
Internal Medicine — Payments: $7,028
Internal Medicine $7,028
Javier Canasi, Md, MD
Internal Medicine — Payments: $4,890
Internal Medicine $4,890